Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Honest communication throughout
SELECT (N=17,604, NEJM 2023): 20% cardiovascular risk reduction sustained over 4 years
doi:10.1007/BF02982659
Based on preclinical (animal and cellular) data only, inhibition of NNMT by 5-Amino-1MQ is theorised to: Raise intracellular NAD+ levels Activate SIRT1 and other sirtuins (proteins linked to metabolic regulation) Reduce fat cell (adipocyte) size and proliferation Improve insulin sensitivity These effects have been demonstrated in mouse models (Neelakantan et al., 2019), but robust human clinical trial data are currently absent
US$ 27.78
US$ 28.65
US$ 26.23
